JScreen

“My husband and I actually found out about JScreen back in college when we were genetics majors at UGA! Flash forward many years and we knew we wanted to get tested before starting to try to have a baby. We both used JScreen and found out we were both carriers of Gaucher’s disease. Ultimately we decided to do IVF so we could genetically test our embryos. Our little baby is now 3 months old! Thankful for the peace of mind that he won’t develop the disease, and now he will have that information when he grows up as well as he is still a carrier. Was really a full circle moment for us, so thank you for what you do!” – J.S. #jscreen #giveaspit #genetictesting #reproductivetesting

Did you know that Ashkenazi Jews have a 10x higher BRCA risk over the general population? Early cancer detection saves lives. That is why is so important to take control of your health and know your risks. Find out more in the link in bio and order your testing kit today. #jscreen #earlydetection #brca #geneticscreening

Know who to talk to this Breast Cancer Awareness Month

Gaucher disease is an autosomal recessive condition, meaning both parents must pass on a mutated copy of the gene for a child to develop the disease. It is particularly common among individuals of Ashkenazi Jewish ancestry, with approximately 1 in 10 people being carriers of a Gaucher gene mutation. This makes it crucial to get tested, along with your partner, before starting a family. Visit the link in our bio to learn more and order your testing kit today! #gaucherdiseaseawareness #geneticscreening

? Uniting for a Healthier Future ? Myriad Genetics and jscreen? are proud to partner in our shared mission to provide community outreach, education, and access to carrier screening and hereditary cancer testing. Together, we’re committed to empowering individuals with the knowledge they need to make informed health decisions, especially within high-risk populations. Discover how this partnership is breaking barriers to health equity and making life-saving genetic testing more accessible than ever. https://lnkd.in/eEQe93yx GlobeNewswire #HealthEquity #GeneticScreening #CommunityOutreach #MyriadGenetics #jscreen #PreventativeCare

@getjscreened mentioned on @theboobiedocs with @sharsheretofficial ?? #jscreen #geneticscreening #theboobiedocs

Know your risk this Breast Cancer Awareness Month The hereditary cancer testing that jscreen provides access to is an expertly curated panel available to those interested in knowing more about their cancer risks. With accessible pricing, and a team of dedicated experts to support you and answer any questions you may have along the way, jscreen is making the testing process as simple and clear as possible. Visit us online at https://bit.ly/4dAK7Ji to purchase your kit today and share this post with your network. One click could save the life of someone you care about. Are you confident you know your risk of developing breast cancer? About 12% of women in the general population will develop breast cancer in their lifetime. You may be surprised to learn that women often overestimate their risk. Interestingly, up to 89% of women at higher risk of breast cancer underestimate their risk of developing the disease. When a genetic mutation in BRCA1 or BRCA2 is at play, that risk can be as high as 85% over the course of a woman’s lifetime. If an individual is positive for a genetic mutation in BRCA1/BRCA2 or another hereditary cancer predisposition gene, risks of cancers, including breast cancers, are significantly elevated over the general population. It is also important to note that men are not immune to these risks, and that breast cancers in men, while overall rare, can occur. Individuals of Ashkenazi Jewish ancestry are at an approximately 1/40 risk of inheriting a mutation in BRCA1/BRCA2, which is ten times higher than those in the general population. Allowing the opportunity for choices about how to manage those risks is one of the main benefits of testing. Risk reducing surgeries and medications are options as well as increased surveillance.

Know your family history this Breast Cancer Awareness Month The hereditary cancer testing that jscreen provides access to is an expertly curated panel available to those interested in knowing more about their cancer risks. With accessible pricing, and a team of dedicated experts to support you and answer any questions you may have along the way, jscreen is making the testing process as simple and clear as possible. Visit us online at https://bit.ly/4dAK7Ji to purchase your kit today and share this post with your network. One click could save the life of someone you care about. A family history of cancer can be one of the most important clues about your own health or the likelihood that you will develop cancer. Sometimes cancer in a family is related to a mutation in a cancer susceptibility gene. While not all families with a strong history of cancer will ultimately test positive for a genetic mutation, a family history of cancer is still a strong indicator of increased risk. Women whose family history of cancer is mostly paternal may not realize that they may be at increased risk as well. Increased breast surveillance, beginning about ten years prior to the earliest diagnosis in the family is recommended for these women. Genetic testing is both appropriate and recommended for any individual with a family history of: - breast cancer(s) diagnosed at or under age 50 - a male relative diagnosed with breast cancer - ovarian, pancreatic and/or metastatic/high-grade prostate cancer - triple negative breast cancer - many individuals on the same side of the family with breast cancer - Ashkenazi Jewish descent If an individual tests positive for a mutation in a cancer gene, they can take action to prevent cancer or detect it at an earlier, more treatable stage. Early detection is key to treatment of cancers, and additional screening recommended for those at higher risk of breast cancer due to mutations in cancer genes can be lifesaving. Screening such as MRIs and mammograms that can detect breast cancers early will be recommended for those at increased risk of breast cancer due to a mutation in a cancer gene like BRCA1 or BRCA2, and should begin at age 25 on an annual basis.

Shari Ungerleider and Myra Sack lost their children to Tay-Sachs disease 25 years apart, prompting them to advocate for genetic screening to prevent similar tragedies. Read the full The Jerusalem Post article here: https://bit.ly/4dduTtB @shariunger @myrasack #JScreen #CancerGen #HealthAwareness #EarlyDetection

Natalie Richeimer, Genetic Counselor at jscreen, is chatting with Dr. Aimee Eyvazzadeh MD, MPH. Tune in on Today, October 10th at 7pm EST on the @eggwhisperer Instagram! #live #geneticcounselor #getjscreened #ovariancancer #geneticscreening #cancergenetics